{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T07:03:20Z","timestamp":1770620600797,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T00:00:00Z","timestamp":1237334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s10072-009-0047-5","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T18:43:09Z","timestamp":1237315389000},"page":"263-267","source":"Crossref","is-referenced-by-count":20,"title":["TNF-related apoptosis-inducing ligand level in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"30","author":[{"given":"Sermin","family":"Genc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehtap Yuksel","family":"Egrilmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdem","family":"Yaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahide","family":"Cavdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Iyilikci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorsev","family":"Yener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kursad","family":"Genc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,18]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00005072-199409000-00003","volume":"53","author":"DJ Selkoe","year":"1994","unstructured":"Selkoe DJ (1994) Alzheimer\u2019s disease: a central role for amyloid. J Neuropathol Expl Neurol 53:438\u2013447","journal-title":"J Neuropathol Expl Neurol"},{"key":"47_CR2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"47_CR3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","volume":"42","author":"ZS Khachaturian","year":"1985","unstructured":"Khachaturian ZS (1985) Diagnosis of Alzheimer\u2019s disease. Arch Neurol 42:1097\u20131105","journal-title":"Arch Neurol"},{"key":"47_CR4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II: standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"47_CR5","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (IV-TR). 4th edn, text revised, Washington DC"},{"key":"47_CR6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman DA, Folstein M, Katzman R, Price DL, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease\u2014report of the NINCDS\u2013ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"issue":"1","key":"47_CR7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2007.09.002","volume":"114","author":"M Motta","year":"2007","unstructured":"Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L (2007) Altered plasma cytokine levels in Alzheimer\u2019s disease: correlation with the disease progression. Immunol Lett 114(1):46\u201351","journal-title":"Immunol Lett"},{"key":"47_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673\u2013682","journal-title":"Immunity"},{"key":"47_CR9","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.2741\/2281","volume":"12","author":"O Aktas","year":"2007","unstructured":"Aktas O, Schulze-Topphoff U, Zipp F (2007) The role of TRAIL\/TRAIL receptors in central nervous system pathology. Front Biosci 12:2912\u20132921","journal-title":"Front Biosci"},{"key":"47_CR10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","volume":"356","author":"R Nitsch","year":"2000","unstructured":"Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U, Zipp F (2000) Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet 356:827\u2013828","journal-title":"Lancet"},{"key":"47_CR11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.4049\/jimmunol.162.4.1889","volume":"162","author":"C Choi","year":"1999","unstructured":"Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahn YS, Kim CH, Kim SJ, Kim JD, Choi IS, Choi IH (1999) Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol 162:1889\u20131895","journal-title":"J Immunol"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0165-2478(02)00245-6","volume":"85","author":"S Genc","year":"2003","unstructured":"Genc S, K\u0131z\u0131ldag S, Ates H, Genc K, Atabey N (2003) LPS and IFN \u03b3 upregulate TNF related Apoptosis Inducing Ligand (TRAIL) expression on murine microglial cells. Immunol Lett 85:271\u2013274","journal-title":"Immunol Lett"},{"key":"47_CR13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/1097-4547(20000815)61:4<464::AID-JNR14>3.0.CO;2-G","volume":"61","author":"M Wu","year":"2000","unstructured":"Wu M, Das A, Tan Y, Zhu C, Cui T, Wong MC (2000) Induction of apoptosis in glioma cell lines by TRAIL\/Apo-2l. J Neurosci Res 61:464\u2013470","journal-title":"J Neurosci Res"},{"key":"47_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00001756-200403220-00002","volume":"15","author":"D Uberti","year":"2004","unstructured":"Uberti D, Cantarella G, Facchetti F, Cafici A, Grasso G, Bernardini R, Memo M (2004) TRAIL is expressed in the brain cells of Alzheimer\u2019s disease patients. Neuroreport 15:579\u2013581","journal-title":"Neuroreport"},{"key":"47_CR15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.cdd.4401143","volume":"10","author":"G Cantarella","year":"2003","unstructured":"Cantarella G, Uberti D, Carsana T, Lombardo G, Bernardini R, Memo M (2003) Neutralization of TRAIL death pathway protects human neuronal cell line from \u03b2-amyloid toxicity. Cell Death Differ 10:134\u2013141","journal-title":"Cell Death Differ"},{"key":"47_CR16","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/sj.npp.1301185","volume":"32","author":"D Uberti","year":"2007","unstructured":"Uberti D, Ferrari-Toninelli G, Bonini SA, Sarnico I, Benarese M, Pizzi M, Benussi L, Ghidoni R, Binetti G, Spano P, Facchetti F, Memo M (2007) Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. Neuropsychopharmacology 32:872\u2013880","journal-title":"Neuropsychopharmacology"},{"key":"47_CR17","doi-asserted-by":"crossref","unstructured":"D\u00f6rr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH, Nitsch R, Zipp F (2002) Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J Neurosci 22:RC209","DOI":"10.1523\/JNEUROSCI.22-04-j0001.2002"},{"key":"47_CR18","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1523\/JNEUROSCI.19-10-03809.1999","volume":"19","author":"A Martin-Villalba","year":"1999","unstructured":"Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM (1999) CD95 ligand (Fas-L\/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 19:3809\u20133817","journal-title":"J Neurosci"},{"key":"47_CR19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/jnr.10815","volume":"74","author":"J Lee","year":"2003","unstructured":"Lee J, Shin JS, Park JY, Kwon D, Choi SJ, Kim SJ, Choi IH (2003) p38 mitogen-activated protein kinase modulates expression of tumor necrosis factor-related apoptosis-inducing ligand induced by interferon-gamma in fetal brain astrocytes. J Neurosci Res 74:884\u2013890","journal-title":"J Neurosci Res"},{"issue":"2","key":"47_CR20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neurobiolaging.2007.06.006","volume":"30","author":"J Ojala","year":"2009","unstructured":"Ojala J, Alafuzoff I, Herukka SK, van Groen T, Tanila H, Pirttil\u00e4 T (2009) Expression of interleukin-18 is increased in the brains of Alzheimer\u2019s disease patients. Neurobiol Aging 30(2):198\u2013209","journal-title":"Neurobiol Aging"},{"key":"47_CR21","doi-asserted-by":"crossref","unstructured":"Blass JP, Zemcov A (1984) Alzheimer\u2019s disease. A metabolic systems degeneration? Neurochem Pathol 2:103\u2013114","DOI":"10.1007\/BF02834249"},{"key":"47_CR22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1532-5415.1993.tb06704.x","volume":"41","author":"RB Scott","year":"1993","unstructured":"Scott RB (1993) Extraneuronal manifestations of Alzheimer\u2019s disease. J Am Geriatr Soc 41:268\u2013276","journal-title":"J Am Geriatr Soc"},{"key":"47_CR23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0197-4580(03)00010-1","volume":"24","author":"G Sala","year":"2003","unstructured":"Sala G, Galimberti G, Canevari C, Raggi ME, Isella V, Facheris M, Appollonio I, Ferrarese C (2003) Peripheral cytokine release in Alzheimer patients: correlation with disease severity. Neurobiol Aging 24:909\u2013914","journal-title":"Neurobiol Aging"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0047-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-009-0047-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0047-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T20:11:33Z","timestamp":1710187893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-009-0047-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,18]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s10072-009-0047-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,18]]}}}